bioAffinity reports 300% sales jump for lung cancer diagnostic
Unit sales for CyPath Lung increased nearly 300% in April 2026 versus the prior year. The company also announced a collaboration with Philips to enhance lung cancer screening for U.S. veterans.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day